TrialJournal of clinical psychopharmacology
Treating Opioid Use Disorder With a Monthly Subcutaneous Buprenorphine Depot Injection: 12-Month Safety, Tolerability, and Efficacy Analysis.
Anne C Andorn et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
trialcites it